VistaGen Therapeutics
VTGN
VTGN
101 hedge funds and large institutions have $387M invested in VistaGen Therapeutics in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.31% less ownership
Funds ownership: 2.46% → 2.15% (-0.31%)
Holders
101
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$28.3M | |
| 2 | +$18.5M | |
| 3 | +$9.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.64M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.23M |
Top Sellers
| 1 | -$6.75M | |
| 2 | -$6.2M | |
| 3 | -$6.02M | |
| 4 |
Millennium Management
New York
|
-$3.84M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$3.46M |